Infectious Diseases

  • The double-tongue sign
    Nami Yoshimura, MD, Takashi Watari, MD, MHQS, MCTM, PhD, Keisuke Misao, MD, Toshihiro Imada, MD and Junji Mashino, MD
    Cleveland Clinic Journal of Medicine August 2022, 89 (8) 435-436; DOI: https://doi.org/10.3949/ccjm.89a.21080

    Computed tomography showed enlarged mylohyoid and geniohyoid muscles, surrounding inflammatory findings, and small gas retentions.

  • Do all patients with primary pulmonary coccidioidomycosis need antifungal therapy?
    Simran Gupta, MD, Nikita Ashcherkin, MD and Janis E. Blair, MD
    Cleveland Clinic Journal of Medicine August 2022, 89 (8) 451-455; DOI: https://doi.org/10.3949/ccjm.89a.21125

    Patients diagnosed with this condition who have no symptoms or are mildly symptomatic do not require treatment and can be closely monitored.

  • An unexpected turn
    Cleveland Clinic Journal of Medicine August 2022, 89 (8) 455;

    The following article in the July 2022 issue contained an error: Ganeshan S, Kelemen B, Dhaliwal G, Zier L. An unexpected turn: A 71-year-old man with myocardial infarction. Cleve Clin J Med. 2022;89(7):401–407. doi:10.3949/ccjm.89a.21030

  • Nontuberculous mycobacterial musculoskeletal infections: Recognizable, when suspected
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 355-356; DOI: https://doi.org/10.3949/ccjm.89b.07022

    Two articles in this issue offer valuable insight into when to suspect these infections in patients who present with swollen, indurated, peripheral soft-tissue structures.

  • Dactylitis from Mycobacterium intracellulare infection
    Hayato Shimizu, MD, Takumi Hashimura, MD and Hiroaki Nishioka, MD, PhD
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 360-362; DOI: https://doi.org/10.3949/ccjm.89a.21067

    A 69-year-old man presents with 6 months of progressive swelling of the right middle finger, with no systemic symptoms.

  • Which ICU patients need stress ulcer prophylaxis?
    Mariam Saeed, MD, Stephanie Bass, PharmD and Neal F. Chaisson, MD
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 363-367; DOI: https://doi.org/10.3949/ccjm.89a.21085

    An examination of the controversy surrounding stress ulcer prophylaxis in critically ill patients, with guidance for its appropriate use in this setting.

  • Unraveling a challenging diagnosis: Role of a TNF inhibitor
    Soumya Chatterjee, MD, MS, FRCP, FACP, FACR
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 368-370; DOI: https://doi.org/10.3949/ccjm.89a.21128

    Painful swelling of the dorsum of the right hand had been diagnosed as chronic cutaneous sarcoidosis with tenosynovitis, treated unsuccessfully with prednisone and methotrexate.

  • An unexpected turn: A 71-year-old man with myocardial infarction
    An unexpected turn: A 71-year-old man with myocardial infarction
    Smitha Ganeshan, MD, MBA, Benjamin Kelemen, MD, Gurpreet Dhaliwal, MD and Lucas Zier, MD, MS
    Cleveland Clinic Journal of Medicine July 2022, 89 (7) 401-407; DOI: https://doi.org/10.3949/ccjm.89a.21030

    The patient’s temperature was elevated, pulse rate 98 beats per minute, respiratory rate 16 breaths per minute, and blood pressure 100/60 mm Hg. Cardiac and pulmonary examinations were normal.

  • Palliative care: An update for internists
    Rachel D. Havyer, MD, FAAHPM, Nauzley Abedini, MD, MSc, Robert L. Jayes, MD, Brenda Matti-Orozco, MD, Daniel H. Pomerantz, MD, MPH and Aziz A. Ansari, DO, SFHM, FAAHPM, FACP
    Cleveland Clinic Journal of Medicine May 2022, 89 (5) 262-268; DOI: https://doi.org/10.3949/ccjm.89a.21075

    A review of recent research to guide symptom management, advance-care planning, and communication training to maximize compassionate care.

  • Treating anemia: It’s not just the EPO
    Brian F. Mandell, MD, PhD
    Cleveland Clinic Journal of Medicine April 2022, 89 (4) 174-175; DOI: https://doi.org/10.3949/ccjm.89b.04022

    Long-term effects of treatment with the new oral inhibitors of prolyl hydroxylase will need to be carefully monitored, as prolyl hydroxylase is a key structural component of diverse proteins.

Pages